Suppr超能文献

急诊科急性主动脉综合征的诊断与处理。

Diagnosis and management of acute aortic syndromes in the emergency department.

机构信息

S.C.U. Medicina d'Urgenza, Ospedale Molinette, A.O.U. Città della Salute e della Scienza, Torino, Italy.

Dipartimento di Scienze Mediche, Università degli Studi di Torino, Torino, Italy.

出版信息

Intern Emerg Med. 2021 Jan;16(1):171-181. doi: 10.1007/s11739-020-02354-8. Epub 2020 May 1.

Abstract

Acute aortic syndromes (AASs) are deadly cardiovascular emergencies involving the thoracic aorta. AASs are relatively rare conditions, have unspecific signs and symptoms (including truncal pain, syncope, neurologic deficit and limb ischemia) and require contrast-enhanced tomography angiography (CTA) of the chest and abdomen for conclusive diagnosis and subsequent therapeutic planning. In the Emergency Department (ED), most patients with potential signs/symptoms of AASs are finally found affected by other alternative diagnoses. Hence, misdiagnosis and delayed diagnosis of AASs are major concerns. In critically ill patients, decision to perform CTA is usually straightforward, as exam benefits largely outweigh risks. In patients with ST-tract elevation on ECG, suspected primary ischemic stroke and in stable patients (representing the most prevalent ED scenarios), proper selection of patients necessitating CTA is cumbersome, due to concurrent risks of misdiagnosis and over-testing. Available studies support an algorithm integrating clinical probability assessment, bedside echocardiography and D-dimer (if the clinical probability is not high). Therapeutic management includes medical therapy for all patients including an opioid and anti-impulse drugs (a beta-blocker and a vasodilator), targeting a heart rate of 60 bpm and systolic blood pressure of 100-120 mmHg. Patients with AASs involving the ascending aorta are likely candidate for urgent surgery, and complicated type B AASs (severe aortic dilatation, impending or frank rupture, organ malperfusion, refractory pain, severe hypertension) necessitate evaluation for urgent endovascular treatment. For uncomplicated type B AASs, optimal medical therapy is the current standard of care.

摘要

急性主动脉综合征(AAS)是涉及胸主动脉的致命心血管急症。AAS 是相对罕见的病症,具有非特异性的体征和症状(包括躯干疼痛、晕厥、神经功能缺损和肢体缺血),需要进行胸部和腹部增强 CT 血管造影(CTA)以明确诊断和随后制定治疗计划。在急诊科(ED),大多数有 AAS 潜在体征/症状的患者最终被发现患有其他替代诊断。因此,AAS 的误诊和延迟诊断是主要关注点。在危重症患者中,进行 CTA 的决定通常是直接的,因为检查的益处大大超过风险。对于心电图上有 ST 段抬高的患者、疑似原发性缺血性中风的患者以及稳定的患者(代表最常见的 ED 情况),由于误诊和过度检查的风险,需要对需要进行 CTA 的患者进行适当选择,这很麻烦。现有研究支持一种整合临床概率评估、床边超声心动图和 D-二聚体(如果临床概率不高)的算法。治疗管理包括所有患者的药物治疗,包括阿片类药物和抗冲动药物(β受体阻滞剂和血管扩张剂),目标是心率为 60 bpm,收缩压为 100-120 mmHg。涉及升主动脉的 AAS 患者可能是紧急手术的候选者,复杂的 B 型 AAS(严重的主动脉扩张、即将破裂或破裂、器官灌注不良、难治性疼痛、严重高血压)需要评估紧急血管内治疗。对于不复杂的 B 型 AAS,最佳药物治疗是目前的标准治疗。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验